February 27, 2013 at 17:52 PM EST
IsoRay, Inc. States Its Policy Not to Comment on Unusual Market Activity

IsoRay, Inc. (NYSE MKT:ISR) ("IsoRay" or the "Company"), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, released the following statement today.

 

In view of the unusual market activity in IsoRay's common stock on February 26 and 27, 2013, the New York Stock Exchange has contacted the Company in accordance with its usual practice. IsoRay stated that its policy is not to comment on unusual market activity.

 

About IsoRay IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body.  Learn more about this innovative   Richland, Washington   company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com .   Join us on http://www.facebook.com/#/Isoray .     Follow us on   https://twitter.com/#!/Isoray .

 

Contact:Worldwide Financial(954) 360-9998info@wwfinancial.com

 

SOURCE IsoRay, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here